CRISPR-Cas9–based treatment of myocilin-associated glaucoma

Autor:	Jain, Ankur, Zode, Gulab, Kasetti, Ramesh B., Ran, Fei A., Yan, Winston, Sharma, Tasneem P., Bugge, Kevin, Searby, Charles C., Fingert, John H., Zhang, Feng, Clark, Abbot F., Sheffield, Val C.
Zdroj:	Proceedings of the National Academy of Sciences of the United States of America, 2017 Oct . 114(42), 11199-11204.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26488941 Zobrazit plný text záznamu